We are live on ! Find out more
ONC

BeOne Medicines Ltd

215 hedge funds and large institutions have $6.06B invested in BeOne Medicines Ltd in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 95 increasing their positions, 64 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $15.8M | Put options by funds: $10.3M

48% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 64

10% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 31

1.35% less ownership

Funds ownership: 6.27%4.92% (-1.3%)

3% less funds holding

Funds holding: 221215 (-6)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

25% less capital invested

Capital invested by funds: $8.11B → $6.06B (-$2.05B)

Holders
215
Holders Change
-6
Holders Change %
-2.71%
% of All Funds
4.74%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.18%
New
28
Increased
95
Reduced
64
Closed
31
Calls
$15.8M
Puts
$10.3M
Net Calls
+$5.49M
Net Calls Change
+$47.8M
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$1.45B
Fidelity Investments
2
Fidelity Investments
Massachusetts
$704M +$49M +313,592 +6%
Capital International Investors
3
Capital International Investors
California
$703M +$181M +1,155,679 +25%
HA
4
HHLR Advisors
Cayman Islands
$674M
Temasek Holdings
5
Temasek Holdings
Singapore
$301M +$27.8M +177,491 +8%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$252M -$38.3M -244,801 -11%
BlackRock
7
BlackRock
New York
$245M +$5.1M +32,639 +2%
Primecap Management
8
Primecap Management
California
$209M +$110M +701,444 +70%
CII
9
Capital International Inc
California
$128M +$12M +76,509 +8%
BC
10
Boxer Capital
California
$114M
State Street
11
State Street
Massachusetts
$105M +$13.2M +84,190 +11%
HSBC Holdings
12
HSBC Holdings
United Kingdom
$91.1M +$51M +325,943 +79%
Invesco
13
Invesco
Georgia
$81.4M +$5.56M +35,523 +6%
AG
14
Artal Group
Luxembourg
$80M +$1.56M +10,000 +2%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$64.2M -$10.7M -68,285 -12%
Sands Capital Management
16
Sands Capital Management
Virginia
$41.7M +$26.8M +171,443 +103%
Northern Trust
17
Northern Trust
Illinois
$38.3M -$46.4M -296,854 -49%
AllianceBernstein
18
AllianceBernstein
Tennessee
$37.3M -$276K -1,767 -0.6%
Baillie Gifford & Co
19
Baillie Gifford & Co
United Kingdom
$37.2M +$2.09M +13,348 +5%
MICM
20
Matthews International Capital Management
California
$33.5M +$9.57M +61,189 +29%
Vanguard Group
21
Vanguard Group
Pennsylvania
$30M -$159M -1,018,860 -81%
VanEck Associates
22
VanEck Associates
New York
$27.2M +$7.32M +46,807 +27%
RSCM
23
Rock Springs Capital Management
Maryland
$26.4M
Legal & General Group
24
Legal & General Group
United Kingdom
$26.1M -$10.5M -67,258 -24%
Bank of America
25
Bank of America
North Carolina
$23.5M -$3.65M -23,329 -11%

ONC Hedge Fund Activity: Q1 2020 in Review

215 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2020, worth a combined $6.06B — down 25% from $8.11B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of ONC and 28 opened new positions — a net loss of 3 holders — while 64 trimmed existing stakes and 95 added.

The largest buyer was Capital International Investors, adding an estimated $181M. The largest seller was Vanguard Group, cutting an estimated $159M.

  • 215 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2020, down from 221 in Q4 2019.
  • Funds reported $6.06B of BeOne Medicines Ltd stock for Q1 2020, down 25% quarter-over-quarter.
  • 28 funds opened new BeOne Medicines Ltd positions in Q1 2020 and 31 closed out, a net change of -3 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2020 was Capital International Investors, an estimated $181M added.
  • The largest BeOne Medicines Ltd seller in Q1 2020 was Vanguard Group, an estimated $159M sold.

Based on aggregated 13F filings for Q1 2020.